Brief: Haemato H1 EBITDA Of EUR 1.69 Mln
Aug 26 (Reuters) - Haemato AG HAEG.DE :
* IN FIRST HALF OF 2019, HAEMATO AG ACHIEVED EBITDA OF EUR 1.69 MILLION. SALES AMOUNTED TO
EUR
94.0 MILLION
* H1 IFRS CONSOLIDATED REVENUE OF EUR 94.0 MILLION (PREVIOUS YEAR PERIOD: EUR 143.7 MILLION)
* H1 RESULT FROM ORDINARY ACTIVITIES (EBITDA) IN AMOUNT OF EUR 1.69 MILLION
Source text for Eikon: ID:nEQ5gdJL8a
Further company coverage: HAEG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Haemato AG
See all newsBrief: HAEMATO Raises FY EBIT Guidance to EUR 10-12 Million
Brief: Haemato Says Terminates Cooperation With Korean Manufacturer Huons Biopharma; To Discontinue Project For A Proprietary Botulinum Toxin
Brief: Haemato Q1 EBITDA At EUR 2.3 Mln
Brief: Haemato To Propose Dividend Of EUR 1.10 Per Share
Brief: Haemato Preliminary Consolidated FY EBIT Up At EUR 11.2 Mln